|
|
Substance Name: Temozolomide [USAN:INN:BAN]
RN: 85622-93-1
UNII: YF1K15M17Y
InChIKey: BPEGJWRSRHCHSN-UHFFFAOYSA-N
Note
- A dacarbazine derivative that is used as an alkylating antineoplastic agent for the treatment of MALIGNANT GLIOMA and MALIGNANT MELANOMA.
Molecular Formula
- C6-H6-N6-O2
Molecular Weight
- 194.1534
Classification Codes
- Alkylating Agents
- Antineoplastic Agents
- Antineoplastic Agents, Alkylating
- Drug / Therapeutic Agent
- Mutation Data
- Noxae
- Treatment of Recurrent High-Grade Gliomas and Advanced Metastatic Melanoma (Alkylating Agent)
* denotes mobile formatted website
Links to Resources
NLM Resources (File Locators)
Other Resources (Internet Locators)
Search for this InChIKey on the Web
Names and Synonyms
Name of Substance
- Temozolomide
- Temozolomide [USAN:INN:BAN]
MeSH Heading
- Temozolomide
Synonyms
- 3,4-Dihydro-3-methyl-4-oxoimidazo(5,1-d)-1,2,3,5-tetrazine-8-carboxamide
- 3,4-Dihydro-3-methyl-4-oxoimidazo(5,1-d)-as-tetrazine-8-carboxamide
- 3-Methyl-4-oxo-3,4-dihydroimidazo(5,1-d)(1,2,3,5)tetrazine-8-carboxamide
- 8-Carbamoyl-3-methylimidazo(5,1-d)-1,2,3,5-tetrazin-4(3H)-one
- BRN 5547136
- CCRG 81045
- CCRG-81045
- CCRIS 8996
- M & B 39831
- M&B 39831
- MB 39831
- Methazolastone
- NSC 362856
- Sch 52365
- Temodal
- Temodar
- Temozolodida
- Temozolodida [Spanish]
- Temozolomide
- Temozolomidum
- Temozolomidum [Latin]
- UNII-YF1K15M17Y
Systematic Names
- 3,4-Dihydro-3-methyl-4-oxoimidazo(5,1-d)-as-tetrazine-8-carboxamide
- Imidazo(5,1-d)(1,2,3,5)tetrazine-8-carboxamide, 3,4-dihydro-3-methyl-4-oxo-
Registry Numbers
CAS Registry Number
- 85622-93-1
FDA UNII
- YF1K15M17Y
System Generated Number
- 0085622931
Structure Descriptors
InChI
InChI=1S/C6H6N6O2/c1-11-6(14)12-2-8-3(4(7)13)5(12)9-10-11/h2H,1H3,(H2,7,13)InChIKey
BPEGJWRSRHCHSN-UHFFFAOYSA-NSmiles
CN1N=Nc2c(ncn2C1=O)Toxicity
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
mouse | LDLo | intraperitoneal | 125mg/kg (125mg/kg) | Cancer Research. Vol. 47, Pg. 5846, 1987. |